Using the power of computational biology to navigate financial markets

background

Proteom has developed a highly successful proprietary investment program based on research by econometrician

Dr Jonathan Kinlay which identifies volatility arbitrage opportunities.

The gene sequencing research by Dr Haftan Eckholdt at Albert Einstein College of Medicine, NYC, has spawned new techniques for investment analysis.

Proteom

Proteom Capital Management Ltd offers sophisticated quantitative hedge fund strategies using proprietary, state-of-the-art econometric, behavioral finance and bioengineering technologies developed in conjunction with the research and consulting firm Investment Analytics

news

Proteom partners with Canadian fund Tanren Corp. in developing its fixed income arbitrage strategy.
Dr Kinlay is speaking at the Hedge Fund Replication conference in NY on Oct 07.

fund performance

'07 YTD

Equity Stat. Arb.

Global Equity L/S

As of end Oct 2007

+19.18%

+24.95%

** Net of fees.

Disclaimer: The material on this web site is for informational purposes only. An investment in the Proteom Fund is not available to the public.